Search research articles
Contact Us
Filters
Showing results (91-100 of 297) with videos related to
Page
of 30
Sort By:
Pharmaceuticals (Basel, Switzerland)
|
July 29, 2023
Cardioprotective Agents for the Primary Prevention of Trastuzumab-Associated Cardiotoxicity: A Systematic Review and Meta-Analysis
Kyriakos Goulas, Dimitrios Farmakis, Anastasia Constantinidou, et al.
Heart Failure Reviews
|
September 2, 2008
Hyponatremia in heart failure
Dimitrios Farmakis, Gerasimos Filippatos, John Parissis, et al.
ESC Heart Failure
|
December 4, 2020
Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
Carsten Tschöpe, Javed Butler, Dimitrios Farmakis, et al.
International Journal of Cardiology
|
May 31, 2014
Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING)
Athanasios Pipilis, Dimitrios Farmakis, Sotirios Kaliambakos, et al.
Journal of Cardiovascular Electrophysiology
|
June 23, 2026
Cardiac Implantable Electronic Devices in Oncology Patients: Challenges and Management
Efstratios Karamanolis, Tereza López-Fernández, Maria Laura Canale, et al.
European Cardiology
|
November 24, 2021
Levosimendan in Europe and China: An Appraisal of Evidence and Context
Xiangqing Kong, Xinqun Hu, Baotong Hua, et al.
European Journal of Heart Failure
|
October 16, 2015
Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm
John Parissis, Dimitrios Farmakis, Apostolos Karavidas, et al.
International Journal of Hematology
|
November 9, 2007
Intensive chelation therapy in beta-thalassemia and possible adverse cardiac effects of desferrioxamine
Athanassios Aessopos, Maria Kati, Dimitrios Farmakis, et al.
The American Journal of Cardiology
|
January 2, 2007
Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients
John T Parissis, Dimitrios Farmakis, Vassiliki Bistola, et al.
European Journal of Haematology
|
October 8, 2025
Predictive Factors and Baseline Risk Stratification for CAR-T Cell Therapy-Related Cardiovascular Toxicity
Dimitrios Farmakis, Konstantinos I Karampinos, Raul Cordoba, et al.
Page
of 30
Search research articles
Search
Showing results (91-100 of 297) with videos related to
Sort By:
Page
of 30
Pharmaceuticals (Basel, Switzerland)
|
July 29, 2023
Cardioprotective Agents for the Primary Prevention of Trastuzumab-Associated Cardiotoxicity: A Systematic Review and Meta-Analysis
Kyriakos Goulas, Dimitrios Farmakis, Anastasia Constantinidou, et al.
Heart Failure Reviews
|
September 2, 2008
Hyponatremia in heart failure
Dimitrios Farmakis, Gerasimos Filippatos, John Parissis, et al.
ESC Heart Failure
|
December 4, 2020
Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
Carsten Tschöpe, Javed Butler, Dimitrios Farmakis, et al.
International Journal of Cardiology
|
May 31, 2014
Anticoagulant therapy is prescribed less often in paroxysmal atrial fibrillation regardless of thromboembolic risk: results from the Registry of Atrial Fibrillation To Investigate New Guidelines (RAFTING)
Athanasios Pipilis, Dimitrios Farmakis, Sotirios Kaliambakos, et al.
Journal of Cardiovascular Electrophysiology
|
June 23, 2026
Cardiac Implantable Electronic Devices in Oncology Patients: Challenges and Management
Efstratios Karamanolis, Tereza López-Fernández, Maria Laura Canale, et al.
European Cardiology
|
November 24, 2021
Levosimendan in Europe and China: An Appraisal of Evidence and Context
Xiangqing Kong, Xinqun Hu, Baotong Hua, et al.
European Journal of Heart Failure
|
October 16, 2015
Functional electrical stimulation of lower limb muscles as an alternative mode of exercise training in chronic heart failure: practical considerations and proposed algorithm
John Parissis, Dimitrios Farmakis, Apostolos Karavidas, et al.
International Journal of Hematology
|
November 9, 2007
Intensive chelation therapy in beta-thalassemia and possible adverse cardiac effects of desferrioxamine
Athanassios Aessopos, Maria Kati, Dimitrios Farmakis, et al.
The American Journal of Cardiology
|
January 2, 2007
Levosimendan for the treatment of acute heart failure syndromes: time to identify subpopulations of responding patients
John T Parissis, Dimitrios Farmakis, Vassiliki Bistola, et al.
European Journal of Haematology
|
October 8, 2025
Predictive Factors and Baseline Risk Stratification for CAR-T Cell Therapy-Related Cardiovascular Toxicity
Dimitrios Farmakis, Konstantinos I Karampinos, Raul Cordoba, et al.
Page
of 30